Joseph C. Galante's Insider Trades & SAST Disclosures
Joseph C. Galante's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 1,000 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph C. Galante.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 1,000 | 61,856 (0%) | 0% | 5.2 | 5,170 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 1.71 per share. | 25 Mar 2024 | 2,500 | 60,856 (0%) | 0% | 1.7 | 4,275 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 1.71 per share. | 25 Mar 2024 | 1,000 | 59,356 (0%) | 0% | 1.7 | 1,710 | Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 989 | 24,168 (0%) | 0% | 0 | PNFP Common Stock | |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.72 per share. | 01 Mar 2024 | 239 | 23,179 (0%) | 0% | 82.7 | 19,770 | PNFP Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 1.92 per share. | 24 Mar 2023 | 1,000 | 58,356 (0%) | 0% | 1.9 | 1,920 | Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,084 | 23,418 (0%) | 0% | 0 | PNFP Common Stock | |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.09 per share. | 01 Mar 2023 | 174 | 22,334 (0%) | 0% | 74.1 | 12,892 | PNFP Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 72.26 per share. | 20 Jan 2023 | 1,000 | 22,508 (0%) | 0% | 72.3 | 72,260 | PNFP Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 01 Jun 2022 | 86 | 48,766 (0%) | 0% | 2.1 | 179 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 01 Jun 2022 | 86 | 48,680 (0%) | 0% | 2.1 | 181 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 01 Jun 2022 | 86 | 48,500 (0%) | 0% | 2.1 | 181 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 01 Jun 2022 | 86 | 48,414 (0%) | 0% | 2.0 | 173 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 01 Jun 2022 | 86 | 48,246 (0%) | 0% | 2.0 | 169 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 01 Jun 2022 | 82 | 48,328 (0%) | 0% | 2.0 | 163 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 01 Jun 2022 | 81 | 47,755 (0%) | 0% | 2.0 | 165 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 01 Jun 2022 | 81 | 47,674 (0%) | 0% | 2.1 | 169 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 01 Jun 2022 | 81 | 47,593 (0%) | 0% | 2.1 | 172 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 01 Jun 2022 | 81 | 47,452 (0%) | 0% | 2.1 | 168 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 01 Jun 2022 | 81 | 48,160 (0%) | 0% | 1.9 | 157 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 1.95 per share. | 01 Jun 2022 | 81 | 48,079 (0%) | 0% | 2.0 | 158 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 01 Jun 2022 | 81 | 47,998 (0%) | 0% | 2.0 | 160 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 01 Jun 2022 | 81 | 47,917 (0%) | 0% | 2.0 | 164 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 01 Jun 2022 | 81 | 47,836 (0%) | 0% | 2.0 | 163 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 01 Jun 2022 | 79 | 48,594 (0%) | 0% | 2.1 | 163 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 01 Jun 2022 | 76 | 47,295 (0%) | 0% | 2.1 | 158 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 01 Jun 2022 | 76 | 47,219 (0%) | 0% | 2.1 | 156 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 01 Jun 2022 | 76 | 47,371 (0%) | 0% | 2.1 | 159 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 01 Jun 2022 | 60 | 47,512 (0%) | 0% | 2.1 | 125 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 01 Jun 2022 | 15 | 48,515 (0%) | 0% | 2.1 | 31 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 02 May 2022 | 76 | 47,143 (0%) | 0% | 2.1 | 162 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 02 May 2022 | 76 | 47,067 (0%) | 0% | 2.1 | 162 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 02 May 2022 | 76 | 46,991 (0%) | 0% | 2.1 | 161 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 02 May 2022 | 76 | 46,915 (0%) | 0% | 2.1 | 163 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 02 May 2022 | 76 | 46,839 (0%) | 0% | 2.2 | 165 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.17 per share. | 02 May 2022 | 76 | 46,763 (0%) | 0% | 2.2 | 165 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.35 per share. | 02 May 2022 | 68 | 46,483 (0%) | 0% | 2.4 | 160 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 02 May 2022 | 68 | 46,687 (0%) | 0% | 2.2 | 152 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 02 May 2022 | 68 | 46,619 (0%) | 0% | 2.3 | 156 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 02 May 2022 | 68 | 46,551 (0%) | 0% | 2.3 | 157 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 02 May 2022 | 68 | 46,415 (0%) | 0% | 2.3 | 157 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.32 per share. | 02 May 2022 | 68 | 46,347 (0%) | 0% | 2.3 | 158 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 02 May 2022 | 68 | 46,279 (0%) | 0% | 2.2 | 152 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.37 per share. | 02 May 2022 | 68 | 46,211 (0%) | 0% | 2.4 | 161 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.54 per share. | 02 May 2022 | 68 | 46,143 (0%) | 0% | 2.5 | 173 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 02 May 2022 | 68 | 46,075 (0%) | 0% | 2.6 | 179 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 02 May 2022 | 61 | 45,763 (0%) | 0% | 2.4 | 149 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 02 May 2022 | 61 | 46,007 (0%) | 0% | 2.4 | 144 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 02 May 2022 | 61 | 45,946 (0%) | 0% | 2.3 | 143 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 02 May 2022 | 61 | 45,885 (0%) | 0% | 2.4 | 145 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 02 May 2022 | 61 | 45,824 (0%) | 0% | 2.4 | 148 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 14 Apr 2022 | 61 | 45,702 (0%) | 0% | 2.4 | 149 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.51 per share. | 14 Apr 2022 | 61 | 45,641 (0%) | 0% | 2.5 | 153 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.41 per share. | 14 Apr 2022 | 61 | 45,580 (0%) | 0% | 2.4 | 147 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 14 Apr 2022 | 61 | 45,519 (0%) | 0% | 2.5 | 154 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 14 Apr 2022 | 61 | 45,458 (0%) | 0% | 2.6 | 160 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 14 Apr 2022 | 56 | 45,173 (0%) | 0% | 2.6 | 147 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.73 per share. | 14 Apr 2022 | 56 | 45,397 (0%) | 0% | 2.7 | 153 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 14 Apr 2022 | 56 | 45,341 (0%) | 0% | 2.8 | 154 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.73 per share. | 14 Apr 2022 | 56 | 45,285 (0%) | 0% | 2.7 | 153 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 14 Apr 2022 | 56 | 45,229 (0%) | 0% | 2.7 | 151 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 14 Apr 2022 | 56 | 45,117 (0%) | 0% | 2.7 | 152 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 2.59 per share. | 16 Mar 2022 | 1,000 | 45,061 (0%) | 0% | 2.6 | 2,590 | Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 790 | 21,508 (0%) | 0% | 0 | PNFP Common Stock | |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.08 per share. | 01 Mar 2022 | 201 | 20,718 (0%) | 0% | 101.1 | 20,317 | PNFP Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 3.22 per share. | 17 Mar 2021 | 1,000 | 32,417 (0%) | 0% | 3.2 | 3,220 | Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2021 | 910 | 21,019 (0%) | 0% | 0 | PNFP Common Stock | |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.17 per share. | 28 Feb 2021 | 314 | 20,009 (0%) | 0% | 81.2 | 25,487 | PNFP Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Sale of securities on an exchange or to another person at price $ 74.03 per share. | 09 Feb 2021 | 4,000 | 20,323 (0%) | 0% | 74.0 | 296,120 | PNFP Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.35 per share. | 10 Jun 2020 | 375 | 24,667 (0%) | 0% | 3.3 | 1,256 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.44 per share. | 10 Jun 2020 | 375 | 24,292 (0%) | 0% | 3.4 | 1,290 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.42 per share. | 10 Jun 2020 | 375 | 23,917 (0%) | 0% | 3.4 | 1,283 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 10 Jun 2020 | 375 | 23,542 (0%) | 0% | 3.3 | 1,223 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.33 per share. | 10 Jun 2020 | 375 | 23,167 (0%) | 0% | 3.3 | 1,249 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 10 Jun 2020 | 375 | 22,792 (0%) | 0% | 3.3 | 1,234 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.31 per share. | 10 Jun 2020 | 375 | 22,417 (0%) | 0% | 3.3 | 1,241 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.37 per share. | 10 Jun 2020 | 375 | 21,742 (0%) | 0% | 3.4 | 1,264 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 10 Jun 2020 | 375 | 21,367 (0%) | 0% | 3.4 | 1,279 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 10 Jun 2020 | 300 | 22,042 (0%) | 0% | 3.3 | 1,002 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.37 per share. | 10 Jun 2020 | 225 | 20,992 (0%) | 0% | 3.4 | 758 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 10 Jun 2020 | 225 | 24,892 (0%) | 0% | 3.3 | 740 | Common Stock |
| Pinnacle Financial Partner... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 03 Jun 2020 | 4,000 | 4,000 | - | 25 | 100,000 | Depositary Shares |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 13 Apr 2020 | 150 | 17,917 (0%) | 0% | 4.1 | 608 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 13 Apr 2020 | 150 | 18,067 (0%) | 0% | 4.0 | 606 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 13 Apr 2020 | 150 | 18,217 (0%) | 0% | 4.0 | 605 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 13 Apr 2020 | 150 | 18,367 (0%) | 0% | 4.0 | 605 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.02 per share. | 13 Apr 2020 | 150 | 18,517 (0%) | 0% | 4.0 | 603 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.01 per share. | 13 Apr 2020 | 150 | 18,667 (0%) | 0% | 4.0 | 602 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.01 per share. | 13 Apr 2020 | 150 | 18,817 (0%) | 0% | 4.0 | 602 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 13 Apr 2020 | 150 | 18,967 (0%) | 0% | 4.0 | 599 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.97 per share. | 13 Apr 2020 | 150 | 19,117 (0%) | 0% | 4.0 | 596 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 4.02 per share. | 13 Apr 2020 | 150 | 19,267 (0%) | 0% | 4.0 | 603 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.93 per share. | 13 Apr 2020 | 150 | 19,417 (0%) | 0% | 3.9 | 590 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.49 per share. | 13 Apr 2020 | 75 | 20,092 (0%) | 0% | 3.5 | 262 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.76 per share. | 13 Apr 2020 | 75 | 19,567 (0%) | 0% | 3.8 | 282 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.83 per share. | 13 Apr 2020 | 75 | 19,642 (0%) | 0% | 3.8 | 287 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.79 per share. | 13 Apr 2020 | 75 | 19,717 (0%) | 0% | 3.8 | 284 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.77 per share. | 13 Apr 2020 | 75 | 19,792 (0%) | 0% | 3.8 | 283 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 13 Apr 2020 | 75 | 19,867 (0%) | 0% | 3.7 | 276 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.61 per share. | 13 Apr 2020 | 75 | 19,942 (0%) | 0% | 3.6 | 271 | Common Stock |
| Cumberland Pharmaceuticals... | Joseph C. Galante | Director | Purchase of securities on an exchange or from another person at price $ 3.59 per share. | 13 Apr 2020 | 75 | 20,017 (0%) | 0% | 3.6 | 269 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges